348 related articles for article (PubMed ID: 30808570)
1. Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability.
Xie Y; Li H; Qi X; Ma Y; Yang B; Zhang S; Chang H; Yin X; Li Z
Vaccine; 2019 Mar; 37(14):2016-2025. PubMed ID: 30808570
[TBL] [Abstract][Full Text] [Related]
2. A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity.
Dong H; Lu Y; Zhang Y; Mu S; Wang N; Du P; Zhi X; Wen X; Wang X; Sun S; Zhang Y; Guo H
J Virol; 2021 Jul; 95(16):e0017721. PubMed ID: 34011545
[TBL] [Abstract][Full Text] [Related]
3. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
[TBL] [Abstract][Full Text] [Related]
4. Novel chimeric foot-and-mouth disease virus-like particles harboring serotype O VP1 protect guinea pigs against challenge.
Li H; Li Z; Xie Y; Qin X; Qi X; Sun P; Bai X; Ma Y; Zhang Z
Vet Microbiol; 2016 Feb; 183():92-6. PubMed ID: 26790940
[TBL] [Abstract][Full Text] [Related]
5. Mutation in the VP2 gene of P1-2A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O.
Ganji VK; Biswal JK; Lalzampuia H; Basagoudanavar SH; Saravanan P; Tamil Selvan RP; Umapathi V; Reddy GR; Sanyal A; Dechamma HJ
Appl Microbiol Biotechnol; 2018 Oct; 102(20):8883-8893. PubMed ID: 30136205
[TBL] [Abstract][Full Text] [Related]
6. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
Zhou G; Wang H; Wang F; Yu L
Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
[TBL] [Abstract][Full Text] [Related]
8. Chimeric Porcine Parvovirus VP2 Virus-like Particles with Epitopes of South African Serotype 2 Foot-and-Mouth Disease Virus Elicits Specific Humoral and Cellular Responses in Mice.
Li Q; Ma X; Shen Y; Dai J; Nian X; Shang X; Chen J; Wubshet AK; Zhang J; Zheng H
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675963
[TBL] [Abstract][Full Text] [Related]
9. Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle.
Guo HC; Sun SQ; Jin Y; Yang SL; Wei YQ; Sun DH; Yin SH; Ma JW; Liu ZX; Guo JH; Luo JX; Yin H; Liu XT; Liu DX
Vet Res; 2013 Jul; 44(1):48. PubMed ID: 23826638
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs.
Terhuja M; Saravanan P; Tamilselvan RP
Biologicals; 2015 Nov; 43(6):437-43. PubMed ID: 26493006
[TBL] [Abstract][Full Text] [Related]
11. Promising MS2 mediated virus-like particle vaccine against foot-and-mouth disease.
Dong YM; Zhang GG; Huang XJ; Chen L; Chen HT
Antiviral Res; 2015 May; 117():39-43. PubMed ID: 25676866
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
[TBL] [Abstract][Full Text] [Related]
13. Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist.
Lei Y; Shao J; Ma F; Lei C; Chang H; Zhang Y
Mol Immunol; 2020 May; 121():118-126. PubMed ID: 32199211
[TBL] [Abstract][Full Text] [Related]
14. Preserved immunogenicity of an inactivated vaccine based on foot-and-mouth disease virus particles with improved stability.
Caridi F; Vázquez-Calvo Á; Borrego B; McCullough K; Summerfield A; Sobrino F; Martín-Acebes MA
Vet Microbiol; 2017 May; 203():275-279. PubMed ID: 28619156
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
[TBL] [Abstract][Full Text] [Related]
16. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
Gullberg M; Lohse L; Bøtner A; McInerney GM; Burman A; Jackson T; Polacek C; Belsham GJ
PLoS One; 2016; 11(6):e0157435. PubMed ID: 27294397
[TBL] [Abstract][Full Text] [Related]
17. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
[TBL] [Abstract][Full Text] [Related]
18. The pH Stability of Foot-and-Mouth Disease Virus Particles Is Modulated by Residues Located at the Pentameric Interface and in the N Terminus of VP1.
Caridi F; Vázquez-Calvo A; Sobrino F; Martín-Acebes MA
J Virol; 2015 May; 89(10):5633-42. PubMed ID: 25762735
[TBL] [Abstract][Full Text] [Related]
19. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R
Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs.
Cao Y; Lu Z; Sun J; Bai X; Sun P; Bao H; Chen Y; Guo J; Li D; Liu X; Liu Z
Vet Microbiol; 2009 May; 137(1-2):10-7. PubMed ID: 19167843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
